Association of two variable number of tandem repeats in the monoamine oxidase A gene promoter with suicide completion: The present study and meta-analysis

1. WHO. World Health Organisation suicide in the world: Global

Health estimates. 2019. Available from: https://www.who.int/publi​

catio​ns/i/item/suici​de-­in-­the-­world. Accessed 9 Sept 2019.

2. Fazel S, Runeson B. Suicide. N Engl J Med. 2020;382(3):266–­74.

3. Liu RT, Miller I. Life events and suicidal ideation and behavior: a

systematic review. Clin Psychol Rev. 2014;34(3):181–­92.

4. McMahon K, Hoertel N, Olfson M, Wall M, Wang S, Blanco C.

Childhood maltreatment and impulsivity as predictors of interpersonal violence, self-­injury and suicide attempts: a national study.

Psychiatry Res. 2018;269:386–­93.

5. Brent DA, Melhem N. Familial transmission of suicidal behavior.

Psychiatr Clin North Am. 2008;31(2):157–­77.

6. Voracek M, Loibl LM. Genetics of suicide: a systematic review of

twin studies. Wien Klin Wochenschr. 2007;119(15–­16):463–­75.

7. Erlangsen A, Appadurai V, Wang Y, Turecki G, Mors O, Werge T,

et al. Genetics of suicide attempts in individuals with and without

mental disorders: a population-­based genome-­wide association

study. Mol Psychiatry. 2020;25(10):2410–­21.

8. Otsuka I, Akiyama M, Shirakawa O, Okazaki S, Momozawa Y,

Kamatani Y, et al. Genome-­wide association studies identify polygenic effects for completed suicide in the Japanese population.

Neuropsychopharmacology. 2019;44(12):2119–­24.

9. Ruderfer DM, Walsh CG, Aguirre MW, Tanigawa Y, Ribeiro JD,

Franklin JC, et al. Significant shared heritability underlies suicide

attempt and clinically predicted probability of attempting suicide.

Mol Psychiatry. 2020;25(10):2422–­3 0.

10. Mann JJ. The serotonergic system in mood disorders and suicidal behaviour. Philos Trans R Soc Lond B Biol Sci. 2013;368(1615):20120537.

11. Hung CF, Lung FW, Hung TH, Chong MY, Wu CK, Wen JK, et al.

Monoamine oxidase a gene polymorphism and suicide: an association study and meta-­analysis. J Affect Disord. 2012;136(3):643–­9.

12. Antypa N, Serretti A, Rujescu D. Serotonergic genes and suicide: a systematic review. Eur Neuropsychopharmacol.

2013;23(10):1125–­42.

13. Philibert RA, Wernett P, Plume J, Packer H, Brody GH, Beach SR.

Gene environment interactions with a novel variable monoamine

oxidase a transcriptional enhancer are associated with antisocial

personality disorder. Biol Psychol. 2011;87(3):366–­71.

14. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase a gene promoter. Hum Genet. 1998;103:273–­9.

15. Courtet P, Jollant F, Buresi C, Castelnau D, Mouthon D, Malafosse

A. The monoamine oxidase a gene may influence the means used in

suicide attempts. Psychiatr Genet. 2005;15(3):189–­93.

16. De Luca V, Tharmalingam S, Sicard T, Kennedy JL. Gene-­gene interaction between MAOA and COMT in suicidal behavior. Neurosci

Lett. 2005;383(1–­2):151–­4.

17. Huang YY, Cate SP, Battistuzzi C, Oquendo MA, Brent D, Mann JJ.

An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse

experiences. Neuropsychopharmacology. 2004;29(8):1498–­505.

18. Manca M, Pessoa V, Lopez AI, Harrison PT, Miyajima F, Sharp H,

et al. The regulation of monoamine oxidase a gene expression

by distinct variable number tandem repeats. J Mol Neurosci.

2018;64(3):459–­70.

19. Tanifuji T, Okazaki S, Otsuka I, Horai T, Shinko Y, Kim S, et al.

Association of two variable number of tandem repeats in the monoamine oxidase a gene promoter with schizophrenia. Neuropsychiatr

Dis Treat. 2021;17:3315–­23.

20. Bortolato M, Chen K, Shih JC. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev.

2008;60(13–­14):1527–­33.

21. Bangasser DA, Cuarenta A. Sex differences in anxiety and

depression: circuits and mechanisms. Nat Rev Neurosci.

2021;22(11):674–­8 4.

22. Becker JB, McClellan ML, Reed BG. Sex differences, gender and

addiction. J Neurosci Res. 2017;95(1–­2):136–­47.

23. Kaczkurkin AN, Raznahan A, Satterthwaite TD. Sex differences

in the developing brain: insights from multimodal neuroimaging.

Neuropsychopharmacology. 2019;44(1):71–­85.

24. LeGates TA, Kvarta MD, Thompson SM. Sex differences in antidepressant efficacy. Neuropsychopharmacology. 2019;44(1):140–­54.

25. Mendrek A, Mancini-­Marie A. Sex/gender differences in the

brain and cognition in schizophrenia. Neurosci Biobehav Rev.

2016;67:57–­78.

26. Rubinow DR, Schmidt PJ. Sex differences and the neurobiology of affective disorders. Neuropsychopharmacology. 2019;44(1):111–­28.

27. Williams OOF, Coppolino M, Perreault ML. Sex differences in neuronal systems function and behaviour: beyond a single diagnosis in

autism spectrum disorders. Transl Psychiatry. 2021;11(1):625.

28. Canetto SS, Cleary A. Men, masculinities and suicidal behaviour.

Soc Sci Med. 2012;74(4):461–­5.

29. Mullins N, Bigdeli TB, Borglum AD, Coleman JRI, Demontis D,

Mehta D, et al. GWAS of suicide attempt in psychiatric disorders

and association with major depression polygenic risk scores. Am J

Psychiatry. 2019;176(8):651–­60.

3 0. Perry LM, Goldstein-­Piekarski AN, Williams LM. Sex differences

modulating serotonergic polymorphisms implicated in the mechanistic pathways of risk for depression and related disorders. J

Neurosci Res. 2017;95(1–­2):737–­62.

31. Cabrera-­Mendoza B, Fresno C, Monroy-­Jaramillo N, Fries GR,

Walss-­Bass C, Glahn DC, et al. Sex differences in brain gene expression among suicide completers. J Affect Disord. 2020;267:67–­77.

32. Dumais A, Lesage AD, Lalovic A, Séguin M, Tousignant M, Chawky

N, et al. Is violent method of suicide a behavioral marker of lifetime

aggression? Am J Psychiatry. 2005;162(7):1375–­8.

33. Shimmyo N, Hishimoto A, Otsuka I, Okazaki S, Boku S, Mouri K,

et al. Association study of MIF promoter polymorphisms with suicide completers in the Japanese population. Neuropsychiatr Dis

Treat. 2017;13:899–­908.

3 4. Kanda Y. Investigation of the freely available easy-­to-­use software 'EZR' for medical statistics. Bone Marrow Transplant.

2013;48(3):452–­8.

35. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis

and visualization of LD and haplotype maps. Bioinformatics.

2005;21(2):263–­5.

36. Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M,

et al. Cochrane Handbook for Systematic Reviews of Interventions

Version 6.3. 2022. Available from: https://train​ing.cochr​ane.org/

handb​ook/current. Accessed 14 Mar 2023.

37. Sanabrais-­Jiménez MA, Aguilar-­García A, Hernández-­Muñoz S,

Sarmiento E, Ulloa RE, Jiménez-­Anguiano A, et al. Association study

2574173x, 2023, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/npr2.12344 by Kobe University, Wiley Online Library on [19/09/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

344 38. 39. 4 0. 41. 42. of catechol-­O-­methyltransferase (COMT) rs4680 Val158Met gene

polymorphism and suicide attempt in Mexican adolescents with

major depressive disorder. Nord J Psychiatry. 2022;76(3):202–­6.

Uršič K, Zupanc T, Paska AV. Analysis of promoter polymorphism

in monoamine oxidase a (MAOA) gene in completed suicide on

Slovenian population. Neurosci Lett. 2018;673:111–­5.

Rahikainen AL, Majaharju S, Haukka J, Palo JU, Sajantila A.

Serotonergic 5HTTLPR/rs25531 s-­allele homozygosity associates

with violent suicides in male citalopram users. Am J Med Genet B

Neuropsychiatr Genet. 2017;174(7):691–­700.

Pompili M, Gentile G, Scassellati C, Bonvicini C, Innamorati M,

Erbuto D, et al. Genetic association analysis of serotonin and signal

transduction pathways in suicide attempters from an Italian sample

of psychiatric patients. Neurosci Lett. 2017;656:94–­102.

Lung FW, Tzeng DS, Huang MF, Lee MB. Association of the MAOA

promoter uVNTR polymorphism with suicide attempts in patients

with major depressive disorder. BMC Med Genet. 2011;12:74.

Ho LW, Furlong RA, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein

DC. Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. Am J

Med Genet. 2000;96(1):36–­42.

S U P P O R T I N G I N FO R M AT I O N

Additional supporting information can be found online in the

Supporting Information section at the end of this article.

How to cite this article: Hasegawa M, Tanifuji T, Okazaki S,

Otsuka I, Shirai T, Shindo R, et al. Association of two variable

number of tandem repeats in the monoamine oxidase A gene

promoter with suicide completion: The present study and

meta-­analysis. Neuropsychopharmacol Rep. 2023;43:338–

345. https://doi.org/10.1002/npr2.12344

2574173x, 2023, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/npr2.12344 by Kobe University, Wiley Online Library on [19/09/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

345

HASEGAWA et al.

...